• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cohance Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
460.85 3 (0.56%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    457.80

  • Today’s High

    464.75

  • Open

    462.00

  • Perv Close

    458.30

  • 52W Low

    266.70

  • 52W High

    1,038.90

Key Indicators

  • P/E(TTM)

    92.03

  • Mar.Cap (₹Cr.)

    17,632.00

  • Div & Yield %

    0.00

  • Book Value(₹)

    117.10

  • Debt-Equity Ratio

    0.56

  • AGM Date

    03-Sep-2026

  • EPS

    5.00

  • P/E Ratio

    92.03

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    17,632.00

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    38.26

  • BV (₹)

    117.10

  • Sales( ₹ in Cr.)

    2,030.50

  • NP (in Cr.)

    249.38

  • NP Var(%)

    -50.0

  • Div%

    0.0

  • CPS (₹)

    10.00

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    17,605.22

  • 52 Week High

    1,038.90

  • 52 Week Low

    266.70

  • Price BSE

    460.0

  • Price NSE

    461.00

  • Market Capital( in Cr.)

    17,605.22

  • P/C Ratio

    46.00

  • P/E Ratio

    70.60

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,030.50 2,504.43 1,051.35 1,330.08 1,320.22 1,009.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,030.50 2,504.43 1,051.35 1,330.08 1,320.22 1,009.72
Other Income 44.73 64.84 56.61 44.55 187.79 14.24
Stock Adjustments 38.58 -110.32 -49.16 20.94 60.35 8.37
Total Income 2,113.81 2,458.95 1,058.80 1,395.57 1,568.36 1,032.33
EXPENDITURE :            
Raw Materials 691.27 699.91 265.88 421.36 459.46 310.32
Power and Fuel Cost 109.60 102.39 48.30 71.35 59.55 44.20
Employee Cost 380.43 396.55 135.23 108.58 100.48 76.23
Other Manufacturing Expenses 213.69 195.14 88.31 101.96 115.25 90.76
Selling and Administration Expenses 180.05 159.61 37.51 43.57 52.38 44.93
Miscellaneous Expenses 69.10 72.08 21.10 13.50 11.17 8.61
Employee Benefit Expenses 380.43 396.55 135.23 108.58 100.48 76.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,644.14 1,625.68 596.33 760.33 798.29 575.05
Operating Profit 469.67 833.27 462.47 635.24 770.08 457.28
Interest 22.46 36.70 7.45 12.75 8.53 11.66
Gross Profit 447.21 796.57 455.02 622.49 761.55 445.62
Depreciation 133.58 146.51 54.60 43.10 39.10 31.64
Profit Before Tax 313.63 650.06 400.42 579.39 722.45 413.98
Current Tax 78.10 171.31 97.36 142.45 157.63 101.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.82 -12.43 6.59 4.34 6.72 3.62
Reported Net Profit 228.71 491.18 296.47 432.60 558.10 308.65
Extraordinary Items -20.67 -11.72 -0.05 10.55 14.53 2.51
Adjusted Net Profit 249.38 502.90 296.52 422.05 543.57 306.14
Adjustment below Net Profit 1.53 0.33 -0.32 -0.26 -0.76 -0.84
P & L Balance brought forward 2,739.59 2,248.08 1,470.91 1,276.39 835.88 568.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 218.65 116.83 40.46
P & L Balance carried down 2,969.83 2,739.59 1,767.06 1,490.07 1,276.39 835.88
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 600.00 500.00 200.00
Dividend Per Share(Rs) 0.00 0.00 0.00 6.00 5.00 2.00
Earnings Per Share-Unit Curr 5.98 19.29 11.64 16.99 21.92 12.12
Earnings Per Share(Adj)-Unit Curr 5.98 19.29 11.64 16.99 21.92 12.12
Book Value 117.10 166.88 79.67 68.72 59.74 41.84
Book Value(Adj)-Unit Curr 117.10 166.88 79.67 68.72 59.74 41.84

Shareholding Pattern

  • Promoter Group

    57.49%

  • Public Share Holding

    42.51%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 219,930,170 57.49 219,930,170 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 219,930,170 57.49 219,930,170 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 40,034 0.01 40,034 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 24,856,830 6.50 24,856,830 107
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,761,779 1.77 6,761,779 2
Mutual Funds / UTI 69,647,356 18.21 69,611,356 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 439,663 0.11 439,663 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 101,745,873 26.60 101,709,873 146
2] Non Institution
Bodies Corporate 27,990,100 7.32 27,986,100 595
Clearing Members 47 0.00 47 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,148,685 0.56 2,148,685 2,608
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 877,928 0.23 877,428 1,508
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,230,855 0.32 1,228,855 4
Individuals holding nominal share capital up to Rs. 1 lakh 28,257,507 7.39 27,939,156 94,275
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,631 0.00 2,631 7
Others 348,438 0.09 348,438 1
Sub Total 60,891,097 15.92 60,566,246 99,001
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 382,567,140 100.00 382,206,289 99,149

Company Background

Cohance Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cohance Lifesciences Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    Vivek Sharma

  • Managing Director

  • Company Secretary

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cohance Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cohance Life 460.15 2,075.23 2,030.50 99.17 7.31
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77